6.6 Multiple Sclerosis and Motor Neurone Disease

Key Takeaways

  • Localise a suspected demyelinating episode and refer for specialist assessment using current diagnostic criteria.

  • Exclude infection and other triggers before labelling worsening multiple sclerosis symptoms as a relapse.

  • In progressive motor weakness, assess bulbar function and ventilation promptly. A normal daytime saturation cannot exclude nocturnal hypoventilation.

Last updated: November 2026

Recognise a demyelinating presentation and refer

An episode of painful monocular visual loss with poorer colour vision, a persistent brainstem syndrome such as binocular diplopia with objective signs, or a spinal cord syndrome can suggest inflammatory central nervous system demyelination. Take a chronology, including past episodes, whether they fully resolved and what function changed. Localise the findings and consider more common or urgent alternatives. Abrupt loss of function can be vascular. Severe spinal pain, progressive weakness or sphincter symptoms can require urgent assessment for compression. Very severe, bilateral or atypical optic neuritis can suggest another inflammatory disorder such as aquaporin-4 or MOG antibody-associated disease.

The Irish HSE model places diagnosis and care with a consultant neurology service and a wider team. The international 2024 McDonald criteria, published in 2025 and incorporated into NICE NG220 in June 2026, use clinical and objective evidence in defined combinations after excluding a better explanation. Characteristic lesions can show dissemination by anatomical location and, when required, by time. The optic nerve can count as a fifth anatomical site under the updated criteria. Several evidence combinations are possible. A documented second attack is not always needed. Specialists interpret brain and spinal MRI, optic nerve tests, and CSF markers such as oligoclonal bands or kappa free light chains in context. Incidental white-matter lesions alone should not prompt an assumption of active demyelinating disease or treatment in primary care.

Established multiple sclerosisReason through the change
New symptoms or deterioration lasting more than 24 hours after at least a month of stability, without an alternative triggerReview for a possible relapse. Document objective change and effects on function and contact the MS team.
Recurrence of previous symptoms with fever, urinary symptoms or another acute illnessAssess and treat the suspected trigger as indicated. Compare with prior deficits; reassess if the symptoms persist after the trigger resolves or there are new concerning signs.
Gradual decline over a prolonged periodConsider progression, comorbidity and rehabilitation needs. A long change does not in itself establish an acute relapse.

Discuss the need for steroids with the MS team. Not every relapse needs them; function-limiting relapses can benefit from an early specialist-directed high-dose methylprednisolone course. Review infection risk and monitoring needs. Decisions about disease-modifying treatment, rehabilitation and symptom support have separate aims. Ask about fatigue, mobility, bladder symptoms and mood, and review the supports and follow-up required.

HSE neurology model, Appendix 3 · 2024 McDonald criteria, published 2025 · NICE NG220, updated June 2026.

Test Your Knowledge

A 36-year-old with established multiple sclerosis reports that her old right-leg stiffness returned yesterday with dysuria, frequency and fever. There is no new neurological deficit. What is the most appropriate initial plan?

A

Arrange assessment for urinary infection and reassess the neurological symptoms after addressing the trigger

B

Automatically begin high-dose steroids for a definite demyelinating relapse

C

Change disease-modifying therapy immediately on the basis of this episode

D

Assume permanent progression and arrange no further review

Identify progressive motor weakness and protect breathing and swallowing

Motor neurone disease can begin with loss of dexterity, weakness of the foot, dysarthria or dysphagia. Amyotrophic lateral sclerosis (ALS) is a form that can combine upper and lower motor neurone signs. Look for increasing weakness, muscle wasting and fasciculations, as well as unexpectedly brisk reflexes or spasticity. The pattern can vary by phenotype and disease stage. Primary prominent sensory symptoms suggest another or additional cause. Cognitive and behavioural changes can accompany the motor syndrome, especially frontotemporal dysfunction.

Refer promptly to neurology when motor neurone disease is suspected. Specialist assessment can use electromyography and nerve conduction studies and other tests to exclude mimics. Consider cervical myelopathy or another structural lesion, neuropathies and neuromuscular junction disease according to the pattern. For instance, wasting and fasciculations accompanying progressive weakness warrant a different work-up from fatigable weakness with fluctuating ptosis. New bulbar symptoms or signs of ventilatory failure require urgency based on airway, respiratory and aspiration risk.

Orthopnoea, morning headaches, weak cough, sleep disruption or daytime somnolence can indicate respiratory muscle weakness. Ask directly rather than waiting for severe breathlessness. A reassuring spot oxygen saturation does not exclude nocturnal hypoventilation. Assess urgently for acute compromise, and arrange respiratory evaluation with measures such as vital capacity and further gas exchange or sleep assessment as indicated. Offer specialist assessment for non-invasive ventilation when respiratory insufficiency is present. Assess swallowing, nutrition, communication, mobility and carer needs in parallel. Discuss feeding support and future care choices while the patient can participate. Under the 2024 EAN guidance, riluzole is offered at diagnosis in ALS, with the local specialist team confirming suitability and monitoring. The Irish model recommends coordinated multidisciplinary care across hospital and community.

HSE neurology model, Appendix 5 · NICE NG42 recognition and respiratory assessment · EAN 2024 ALS guideline · HPRA riluzole Irish product information.

Test Your Knowledge

A 61-year-old with progressive hand wasting, fasciculations and brisk knee reflexes is undergoing investigation for motor neurone disease. He has developed orthopnoea, weak cough and morning headaches. Daytime room-air oxygen saturation is 97% and he has no current respiratory distress. What is the most appropriate next step?

A

Wait for a low daytime oxygen saturation before acting

B

Start oxygen alone at night without assessing ventilation

C

Arrange prompt neuromuscular respiratory assessment for hypoventilation and possible ventilatory support

D

Delay respiratory assessment until the diagnosis has been formally confirmed

Sections you finish are checked off in the contents.